Bicitropeptide, antacid and placebo gastric and duodenal ulceration - a two-centre, double-blind, comparative endoscopic study

A bismuth-peptide complex (BCP Compound), an antacid (Maalox) and corresponding placebos were studied in a 6-week comparative double-blind trial of treatment in 106 randomized ambulant patients with endoscopically proven duodenal and gastric ulcers.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	South African medical journal 1979-01, Vol.55 (2), p.43-46
1. Verfasser:	Mekel, R.C.P.M., Serfontein, W.J., Bank, S., Barbezat, G.O. & Novis, B.H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antacid Antacids - therapeutic use Bicitropeptide Bismuth - therapeutic use Chemical pathology Clinical Trials as Topic Double-Blind Method Drug Evaluation Duodenal Ulcer - drug therapy Duodenal ulceration Female Gastric ulcer Gastroenterology Humans Male Peptic Ulcer - drug therapy Placebos Proteins - therapeutic use Symptoms
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A bismuth-peptide complex (BCP Compound), an antacid (Maalox) and corresponding placebos were studied in a 6-week comparative double-blind trial of treatment in 106 randomized ambulant patients with endoscopically proven duodenal and gastric ulcers.
ISSN:	0256-9574 2078-5135